Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding
- PMID: 9007977
- PMCID: PMC2143522
- DOI: 10.1002/pro.5560060107
Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding
Abstract
The tertiary structure of a unique C5a receptor antagonist was determined by two-dimensional NMR spectroscopy. The core domain of this 8-kDa antagonist exists as an antiparallel helical bundle, similar to recombinant human (rh)-C5a. However, unlike C5a, the antagonist's C terminus was found to be conformationally restricted along a groove between helices one and four in the core domain. This conformational restriction situates C-terminal D-Arg 75 in a wedge between core residues Arg 46 and His 15. Correlation of the antagonist's tertiary structure with point mutation analysis revealed the formation of a positively charged contiguous contact surface comprised of D-Arg 75, Arg 46, Lys 49, and His 15. The significance of this surface in generating antagonist properties implies a single binding site with the C5a receptor and provides a structural template for drug design.
Similar articles
-
Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.J Med Chem. 1998 Aug 27;41(18):3417-25. doi: 10.1021/jm9800651. J Med Chem. 1998. PMID: 9719594
-
Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.J Med Chem. 1999 Jun 3;42(11):1965-74. doi: 10.1021/jm9806594. J Med Chem. 1999. PMID: 10354404
-
Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.J Biol Chem. 1998 Apr 24;273(17):10411-9. doi: 10.1074/jbc.273.17.10411. J Biol Chem. 1998. PMID: 9553099
-
C5a receptor antagonists.Curr Pharm Des. 1999 Oct;5(10):737-55. Curr Pharm Des. 1999. PMID: 10526086 Review.
-
Pulmonary inflammation--a balancing act.N Engl J Med. 1997 Apr 10;336(15):1094-6. doi: 10.1056/NEJM199704103361511. N Engl J Med. 1997. PMID: 9091809 Review. No abstract available.
Cited by
-
Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.Am J Pathol. 2001 Dec;159(6):2293-301. doi: 10.1016/S0002-9440(10)63079-9. Am J Pathol. 2001. PMID: 11733378 Free PMC article.
-
What does complement do in Alzheimer's disease? Old molecules with new insights.Transl Neurodegener. 2013 Oct 12;2(1):21. doi: 10.1186/2047-9158-2-21. Transl Neurodegener. 2013. PMID: 24119446 Free PMC article.
-
Structural basis for therapeutic inhibition of complement C5.Nat Struct Mol Biol. 2016 May;23(5):378-86. doi: 10.1038/nsmb.3196. Epub 2016 Mar 28. Nat Struct Mol Biol. 2016. PMID: 27018802 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases